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Abstract
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal
syndrome characterized by intravascular hemolysis mediated by
complement, thrombotic events and alterations in hematopoiesis.
Basically, the molecular events which underlie the complexity of the
syndrome consist of the absence of the glycosylphosphatidylinositol
(GPI) anchor as a consequence of somatic mutations in the PIG-A
gene, located on the X chromosome. The GPI group is responsible for
the attachment of many proteins to the cytoplasmic membrane. Two of
them, CD55 and CD59, have a major role in the inhibition of the action
of complement on the cellular membrane of blood cells. The absence
of GPI biosynthesis can lead to PNH. Since mutations in the PIG-A
gene are always present in patients with PNH, the aim of this study was
to characterize the mutations in the PIG-A gene in Brazilian patients.
The analysis of the PIG-A gene was performed using DNA samples
derived from bone marrow and peripheral blood. Conformation-
sensitive gel electrophoresis was used for screening the mutation and
sequencing methods were used to identify the mutations. Molecular
analysis permitted the identification of three point mutations in three
patients: one G®A transition in the 5 portion of the second intron,
one T®A substitution in the second base of codon 430 (Leu430®stop),
and one deletion DA in the third base of codon 63. This study
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(PNH) is an acquired hematological syn-
drome characterized by chronic intravascu-
lar hemolysis mediated by complement,
thrombotic events and alterations in hemato-
poiesis (1-3). The molecular alterations which
underlie the complexity of the syndrome are
relatively simple (4-7). Basically, they con-
sist of the absence of the glycosylphosphati-
dylinositol (GPI) group, responsible for the
attachment of several proteins in the cyto-
plasmic membrane (8), as a consequence of
somatic mutations in the PIG-A gene located
on the short arm of the X chromosome (9,10).
The GPI group attaches about 20 proteins
to the blood cells membrane (6). At least
two of them, CD55 (decay accelerating fac-
tor) and CD59 (membrane inhibitor of reac-
tive lysis), are involved in the inhibition of
the action of complement on the blood cell
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membrane. Thus, the absence of GPI bio-
synthesis can lead to PNH.
Since mutations in the PIG-A gene are
always present in patients with PNH (11-
16), and to the best of our knowledge there is
no previous report of these mutations in
Brazil, the aim of the present study was to
characterize somatic mutations in the PIG-A
gene in Brazilian patients with PNH.
Material and Methods
Three PNH patients (1 female aged 25
years and 2 males aged 17 and 65 years)
were investigated. The diagnosis of PNH
was based on clinical and laboratory fea-
tures (1). This study was approved by the
Ethics Committee (Hemocentro, UNICAMP)
and the patients gave informed written con-
sent. The quantification of GPI-linked sur-
face proteins on red blood cells and granulo-
cytes was performed by flow cytometry
(FACScan; Becton-Dickson, Mountain
View, CA, USA) using monoclonal antibod-
ies towards GPI-linked surface antigens
(CD59 and CD55). Peripheral venous blood
and bone marrow samples were collected
with EDTA as anticoagulant after obtaining
informed patient consent. Genomic DNA
derived from these samples was extracted by
the Trisol method (Gibco-BRL, Rockville,
MD, USA), which involves a monophasic
reagent with a phenol and guanidine isothio-
cyanate solution. Contaminating erythrocytes
in the preparations were removed by hypo-
tonic lysis.
The promoter and coding regions (in-
cluding exon/intron boundaries) of the PIG-
A gene were amplified from genomic DNA
using six pairs of primers for 35 cycles (10).
The PCR products were screened for muta-
tions by conformation-sensitive gel electro-
phoresis (CSGE), a variation of the method
of heteroduplex analysis (17). The muta-
tions were identified by direct sequencing
with the Sequenase kit version 2.0. When
necessary, the PCR products were cloned in
the pUC18 plasmid and sequenced.
Results
CSGE analysis and sequencing permit-
ted the detection of the mutation in each of
the three patients. The results are given in
Table 1.
The first mutation identified in fragment
2B (patient PNH1) was a G®A transition in
the second intron 5 portion (Figure 1, indi-
cated by the arrow). The second mutation
detected in fragment 6A (patient PNH2) was
a T®A transversion in the second base of
codon 430 (Figure 2). The identification of
the third mutation, a deletion of one nucleo-
tide A in the third base position of codon 63
(fragment 2A; patient PNH3), was only pos-
sible after subcloning the PCR product in a
bacterial vector, which allowed the separa-
tion of the normal and mutant sequences
(Figure 3).C T A G C T A G
Figure 1. Nucleotide sequence
of fragment 2B with a G®A sub-
stitution in the 5' portion (ar-
row) of the second intron found
in patient PNH1. From left to
right: control and the abnormal
sequence derived from the
patient’s bone marrow sample.




Table 1. Mutations detected in patients with paroxysmal nocturnal hemoglobinuria
(PNH).
Patients Age Sex Altered fragment* Mutation Type
(years) (CSGE scan) (codon)
PNH1 25 Female Fragment 2B agg®aga Splicing defect
PNH2 17 Male Fragment 6A 430TTG®TAG Nonsense
PNH3 65 Male Fragment 2A 63GAG®G_G Frameshift
*The amplification fragments were those described by Iida et al. (see Ref. 10).
CSGE, conformation-sensitive gel electrophoresis.
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Discussion
The mutations detected in patients PNH1
and PNH2 have not been described in the
literature. The first one, the G®A substitu-
tion in the conserved region at the 5 extrem-
ity of the second intron, is possibly disturb-
ing the normal splicing mechanism in the
mutant gene. The latter is a T®A substitu-
tion in the second base of codon Leu430 in
exon 6, leading to the formation of one pre-
cocious stop codon in this position (non-
sense mutation). Due to this, at least 54
amino acids are not expressed. This region
corresponds to two distinct protein domains,
and by homology to other proteins, the re-
gion between amino acids 422 and 442 is
described as a transmembrane domain. The
region between amino acids 443 and 484
probably corresponds to the portion of the
protein located in the lumen of the endoplas-
mic reticulum (http://www.expasy.ch). In this
case, the resulting peptide may not be com-
pletely dysfunctional since the enzymatic
domains seem to be located in the second
exon (18). The third mutation (patient PNH3)
has already been described (14). The loss of
one nucleotide A in the third base of the
Arg63 codon is responsible for the produc-
tion of one truncated peptide with only 67
amino acids.
Somatic mutations in the PIG-A gene are
heterogeneous, without defined etiological
characteristics. More than 148 mutations have
been described (16), spanning the entire lo-
cus. These are mainly frameshifts involving
one or two nucleotides (5,14). Point muta-
tions occurred in approximately 37% of the
PNH cases studied, with a majority of mis-
sense mutations (5). However, comparative
observation indicates discrepancies in the
frequencies of the emergency of mutation
types (frameshifts versus substitutions) in
different populations analyzed (12-14). Dif-
ferences in the mutational spectra of the
PIG-A gene may be related to the specific
genetic background of these populations and/
or to previous exposure to genotoxic agents
(19,20).
This study represents the first description
of somatic mutations in the PIG-A gene in a
Brazilian population. In this respect, analy-
sis of somatic mutations in the PIG-A gene in
Brazil could represent a new source of com-
parative mutation data. The results obtained
suggest the emergence of two novel point
mutations in Brazilian patients with PNH.
However, in view of the small number of
patients, further studies are needed to obtain
a comprehensive mutation profile of the PIG-
A gene in Brazil.
G A T C G A T C
Control PNH2
Figure 2. Nucleotide sequence
of fragment 6A with a T®A sub-
stitution in the second base of
codon Leu430 (arrow) in patient
PNH2. From left to right: control
and the sample derived from
bone marrow showing the ab-
normal sequence. PNH, parox-
ysmal nocturnal hemoglobinuria.
C T A G C T A G
Normal sequence Mutant sequence
Figure 3. From left to right: nor-
mal and variant sequences de-
rived from fragment 2A of pa-
tient PNH3. The deletion of one
nucleotide A in the third base of
the Arg63 codon (arrow) is re-
sponsible for the production of
one truncated peptide with only
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